http://www.mmm-online.com/warning/topic/217/ Articles tagged with Warning from Medical Marketing and Media MMM mmmsubs@haymarketmedia.com no The FDA is asking healthcare professionals to keep an eye out for violative promotion and to call 1-877-RX-DDMAC or emailing badad@fda.com when they see it. "Recognize and report" is the message of the agency's Bad Ad Program, an educational outreach effort by the Division of Drug Marketing, Advertising and Communications (DDMAC) that will "help healthcare providers recognize misleading prescription drug promotion and provide them with an easy way to report this activity to the agency," according to DDMAC director Tom Abrams. http://www.mmm-online.com/hows-my-detailing-dial-1-877-rx-ddmac/article/169959/ Tue, 11 May 2010 19:12:39 GMT The FDA is asking healthcare professionals to keep an eye out for violative promotion and to call 1-877-RX-DDMAC or emailing badad@fda.com when they see it. "Recognize and report" is the message of the agency's Bad Ad Program, an educational outreach effort by the Division of Drug Marketing, Advertising and Communications (DDMAC) that will "help healthcare providers recognize misleading prescription drug promotion and provide them with an easy way to report this activity to the agency," according to DDMAC director Tom Abrams. MMM The FDA hit Johnson & Johnson with a warning letter over a webcast promoting pain med Ultram ER, saying it overstated efficacy and underplayed or omitted risks. http://www.mmm-online.com/ddmac-warns-jj-on-ultram-webcast/article/137152/ Wed, 20 May 2009 17:41:46 GMT The FDA hit Johnson & Johnson with a warning letter over a webcast promoting pain med Ultram ER, saying it overstated efficacy and underplayed or omitted risks. MMM The FDA's Division of Drug Marketing, Advertising and Communications slapped 14 drug companies with untitled letters for sponsored links on Google deemed violative because they omitted risk information. http://www.mmm-online.com/ddmac-raps-sponsored-links-for-omission-of-risk-info/article/130180/ Mon, 06 Apr 2009 17:45:32 GMT The FDA's Division of Drug Marketing, Advertising and Communications slapped 14 drug companies with untitled letters for sponsored links on Google deemed violative because they omitted risk information. MMM Bayer is shelling out $20 million to air a rare remedial TV ad campaign for its Yaz birth control pill as part of a settlement with FDA and 27 states over charges of deceptive advertising. Bayer also agreed to submit all ads to FDA for preclearance for the next six years. http://www.mmm-online.com/bayer-runs-corrective-yaz-ad-agrees-to-preclearance/article/127205/ Wed, 11 Feb 2009 18:10:14 GMT Bayer is shelling out $20 million to air a rare remedial TV ad campaign for its Yaz birth control pill as part of a settlement with FDA and 27 states over charges of deceptive advertising. Bayer also agreed to submit all ads to FDA for preclearance for the next six years. MMM KV Pharmaceutical Company said it is eliminating 700 jobs as part of a cost-cutting program following a suspension of manufacturing and product recalls resulting from an FDA investigation. http://www.mmm-online.com/troubled-kv-cuts-700-jobs-amid-suspension/article/127119/ Mon, 09 Feb 2009 22:40:53 GMT KV Pharmaceutical Company said it is eliminating 700 jobs as part of a cost-cutting program following a suspension of manufacturing and product recalls resulting from an FDA investigation. MMM The FDA's Division of Drug Marketing, Advertising and Communications issued 21 warning and untitled letters in 2008 - scarcely more than the 20 letters the unit sent out in 2007. http://www.mmm-online.com/ddmac-warning-and-untitled-letters-in-2008-total-21/article/123478/ Wed, 31 Dec 2008 20:03:41 GMT The FDA's Division of Drug Marketing, Advertising and Communications issued 21 warning and untitled letters in 2008 - scarcely more than the 20 letters the unit sent out in 2007. MMM Unreadable risk info was at issue in an FDA rebuke of an Abbott ad for Humira. http://www.mmm-online.com/fda-raps-tiny-text-in-abbott-ad/article/123399/ Mon, 29 Dec 2008 22:33:12 GMT Unreadable risk info was at issue in an FDA rebuke of an Abbott ad for Humira. MMM Results from a large national study may have put the nail in the coffin of hormone replacement therapy (HRT) treatments, the Associated Press reported Saturday. http://www.mmm-online.com/new-study-results-strengthen-hormone-therapy-cancer-link/article/122891/ Mon, 15 Dec 2008 22:41:15 GMT Results from a large national study may have put the nail in the coffin of hormone replacement therapy (HRT) treatments, the Associated Press reported Saturday. MMM The FDA's Division of Drug Marketing, Advertising and Communications issued an "untitled/notice of violation" letter on a patient brochure for Amgen's Sensipar, which is indicated for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis. http://www.mmm-online.com/ddmac-warns-amgen-bayer-on-consumer-promotions/article/120193/ Thu, 30 Oct 2008 17:48:03 GMT The FDA's Division of Drug Marketing, Advertising and Communications issued an "untitled/notice of violation" letter on a patient brochure for Amgen's Sensipar, which is indicated for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis. MMM The FDA slapped Bayer HealthCare Pharmaceuticals with a warning letter on two 60-second TV ads for its YAZ contraceptive. http://www.mmm-online.com/ddmac-warns-bayer-on-yaz-tv-ads/article/119173/ Tue, 07 Oct 2008 22:02:22 GMT The FDA slapped Bayer HealthCare Pharmaceuticals with a warning letter on two 60-second TV ads for its YAZ contraceptive. MMM